Supernus Pharmaceuticals Income Taxes 2011-2024 | SUPN
Supernus Pharmaceuticals income taxes from 2011 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Supernus Pharmaceuticals Annual Income Taxes
(Millions of US $) |
| 2023 |
$1 |
| 2022 |
$0 |
| 2021 |
$20 |
| 2020 |
$42 |
| 2019 |
$34 |
| 2018 |
$29 |
| 2017 |
$43 |
| 2016 |
$-41 |
| 2015 |
$1 |
| 2014 |
$1 |
| 2013 |
$0 |
| 2012 |
$ |
| 2011 |
$-16 |
| 2010 |
$-0 |
Supernus Pharmaceuticals Quarterly Income Taxes
(Millions of US $) |
| 2024-09-30 |
$6 |
| 2024-06-30 |
$6 |
| 2024-03-31 |
$0 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$26 |
| 2023-06-30 |
$-16 |
| 2023-03-31 |
$-8 |
| 2022-12-31 |
$10 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$3 |
| 2022-03-31 |
$-11 |
| 2021-12-31 |
$-0 |
| 2021-09-30 |
$7 |
| 2021-06-30 |
$8 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$9 |
| 2020-09-30 |
$13 |
| 2020-06-30 |
$13 |
| 2020-03-31 |
$8 |
| 2019-12-31 |
$8 |
| 2019-09-30 |
$11 |
| 2019-06-30 |
$10 |
| 2019-03-31 |
$6 |
| 2018-12-31 |
$13 |
| 2018-09-30 |
$8 |
| 2018-06-30 |
$3 |
| 2018-03-31 |
$5 |
| 2017-12-31 |
$21 |
| 2017-09-30 |
$7 |
| 2017-06-30 |
$9 |
| 2017-03-31 |
$6 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$-43 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
|
| 2014-09-30 |
$0 |
| 2014-06-30 |
|
| 2014-03-31 |
$0 |
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$-16 |
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.000B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
